Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Natural Alternatives International Inc

NAII ✓ COMPLIANTFree checks used up today ☆ Track — members

NASDAQ · Healthcare · Pharmaceuticals ·

USA Micro Cap Analyst: N/A

Last Close

$1.87

▲ +0.00%

Market Cap $11.73M · Vol 4.29K

Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$11.73M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

22.73

Momentum

Beta

0.28

vs Market

52W High

$4.95

62.22% below

52W Low

$1.87

0.00% above

Volume

4.29K

Avg 10.30K

P/B

0.30

Price-to-book

ROE

N/A

Return on equity

Free Float

78.32%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Natural Alternatives International Inc (NAII) stock is Shariah compliant

You’ve used your 10 free compliance checks today

Choose a plan

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does NAII pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-4.59%

-13.02%

-29.96%

-26.95%

YTD

-47.77%

-40.06%

-70.34%

-87.06%

Financials & Valuation

TTM · Annual

Total Revenue	$129.86M
Net Income	$-13,575,000.00
Revenue Growth (YoY)	+23.35%
Gross Margin	7.15%
Operating Margin	-5.59%
Net Profit Margin	-10.45%
ROE	N/A
ROA · ROIC	-6.83% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	0.15
P/B	0.30
P/FCF	8.41
EPS Growth	N/A
Outstanding Shares	6.28M

Technical Indicators

50-Day SMA	$2.16
200-Day SMA	$2.78
RSI (14)	22.73
Beta	0.28
52-Week High	$4.95
52-Week Low	$1.87

Volume Today	4.29K
Avg Daily Volume (30D)	10.30K
Relative Volume	0.42x
Volatility (10D)	29.91
Volatility (30D)	46.32
Free Float	78.32%

Analyst Consensus

N/A

Current Price $1.87

Mean Target N/A

52W Low$1.87 52W High$4.95

Current

Target

$1.87 $4.95

Current Analyst target

· 0 analysts

Identifiers

ExchangeNASDAQ

FIGIBBG001S7FBJ0

ISINUS6388423021

CountryUSA

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeADR American Depositary Receipt

Similar Halal Stocks

LLY Eli Lilly and Company +1.04% JNJ Johnson & Johnson -0.19% ABBV AbbVie Inc. +0.20% NVS Novartis AG +0.43% NOVN.S Novartis AG +0.90%

Company Profile

Natural Alternatives International, Inc. is a formulator, manufacturer and marketer of nutritional supplements. Its primary business activity is to provide private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbs, and other nutritional supplements, as well as other health care products, to consumers both within and outside the United States. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer ecommerce channels, and retail stores. It manufactures products in a variety of forms, including capsules, tablets, chewable wafers, and powders to accommodate a variety of its customer's preferences. It also seeks to commercialize its patent and trademarks through the direct distribution and sale of CarnoSyn, SR CarnoSyn, TriBsyn, new contract manufacturing opportunities, and various license, royalty, and similar arrangements.